Start / Radiology Podcasts | RSNA / Quantitative 68ga psma 11 pet and outcomes in metastatic castration resistant prostate cancer following 177lu psma 617

Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617

31 min • 22 oktober 2024

Dr. Ashwin Singh Parihar speaks with Dr. Phillip Kuo, Dr. Andrew Armstrong, and Dr. Ken Herrmann about how 68Ga-PSMA-11 PET can predict response of metastatic prostate cancer following 177Lu-PSMA-617 therapy. The VISION Trial.

Quantitative 68Ga-PSMA-11 PET and ClinicalOutcomes in Metastatic Castration-resistant ProstateCancer Following 177Lu-PSMA-617 (VISION Trial). Kuo and Morris et al. Radiology 2024; 312(2):e233460.

Kategorier

Hälsa och motion Medicin Poddar Vetenskap

Förekommer på

Vetenskap

00:00 -00:00